Brain Metastases
From Anvita Health Wiki
(Redirected from Metastasis To Brain)
Contents |
Etiology
- lung cancer (most common)
- ~37% metastasize to brain
- accounts for ~50% of metastatic brain tumors
- ~23% metastasize to brain
- account for ~15-20% of metastatic brain tumors
- ~40% metastasize to brain
- accounts for ~10% of metastatic brain tumors
- ~11% metastasize to brain
- accounts for ~5% of metastatic brain tumors
- renal cell carcinoma: ~19% metastasize to brain
- lymphoma & leukemia tend to involve leptomeninges more than brain parenchyma (see carcinomatous meningitis)
- adenocarcinoma of the esophagus
- cervical carcinoma: ~9% metastasize to brain
- prostate carcinoma: ~2% metastasize to brain
- unknown primary 10%
- Single metastasis more common:
- Multiple metastases more common:
Epidemiology
- most common form of brain tumor, accounting for > 50% of brain tumors in adults
- occurs in ~10-30% of adults with cancer; ~6-10% of children with cancer
- ~98,000 -170,000 new cases per year
Pathology
- distribution:
- ~80% cerebral hemispheres
- ~15% cerebellum
- ~5% brainstem
- GI & pelvic tumors have predilection to metastasize to posterior fossa
- metastases tend to be located at the gray-white junction where blood vessels decrease in diameter
- leptomeningeal metastases common with lymphoma/ leukemia but may occur with any cancer metastasizing to the brain
Genetics
- defects in EPHB2 may be associated with prostate cancer metastasis to the brain
Clinical-manifestations
-
- headache or spine pain
- cranial nerve pain or spinal radicular pain
- mental status changes
Laboratory
-
- indications: suspected leptomeningeal metastasis but negative MRI
- elevated CSF protein
- diminished CSF glucose
- positive CSF cytology
Radiology
- magnetic resonance imaging ( MRI)
- computed tomography ( CT) if MRI is unavailable
- communicating hydrocephalus may be apparent with leptomeningeal metastasis
Complications
Differential-diagnosis
Management
- radiotherapy & surgery for single brain metastasis
-
- good performance status
- minimal or no evidence of extracranial disease
- accessible lesion that can be completely excised
- postoperative whole brain radiotherapy
- radiotherapy for multiple brain metastases
- whole brain radiation
- 3,000 cGy in 10 fractions or 2,000 cGy in 5 fractions
- optimal use of radiosurgery undefined
- chemotherapy followed by radiation therapy
- indication: leptomeningeal metastasis
- methotrexate & cytarabine
- glucocorticoids as initial adjunctive therapy for parenchymal & leptomeningeal metastasis
- supportive care
More General Terms
Internet Database
OMIM: 03688
References
- Saunders Manual of Medical Practice, Rakel (ed), WB Saunders, Philadelphia, 1996, pg 1068-70
- Medical Knowledge Self Assessment Program (MKSAP) 14, American College of Physicians, Philadelphia 2006
- National Guideline Clearinghouse
- Management of single brain metastases: a clinical practice guideline. (Program in Evidence-based Care) ngc-guideline: [1]
- Pre-irradiation evaluation and management of brain metastases. (American College of Radiology) ngc-guideline: [2]
- Single brain metastasis. (American College of Radiology) ngc-guideline: [3]
- Follow-up and retreatment of brain metastases. (American College of Radiology) ngc-guideline: [4]
- Multiple brain metastases. (American College of Radiology) ngc-guideline: [5]
- Brain metastases. European Federation of Neurological Societies ngc-guideline: [6]
- The role of chemotherapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. Congress of Neurological Surgeons ngc-guideline: [7]
- The role of emerging and investigational therapies for metastatic brain tumors: a systematic review and evidence- based clinical practice guideline of selected topics. Congress of Neurological Surgeons ngc-guideline: [8]
- The role of prophylactic anticonvulsants in the management of brain metastases: a systematic review and evidence-based clinical practice guideline. Congress of Neurological Surgeons ngc-guideline: [9]
- The role of retreatment in the management of recurrent/ progressive brain metastases: a systematic review and evidence-based clinical practice guideline. Congress of Neurological Surgeons ngc-guideline: [10]
- The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. Congress of Neurological Surgeons ngc-guideline: [11]
- The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline. Congress of Neurological Surgeons ngc-guideline: [12]
- The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence- based clinical practice guideline. Congress of Neurological Surgeons ngc-guideline: [13]
- The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. Congress of Neurological Surgeons ngc-guideline: [14]
